Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance

Published:2018-02 Issue:1 Volume:40 Page:84-92
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Eva Choong,Chakradhara Rao Satyanarayana Uppugunduri,Denis Marino,Melanie Kuntzinger,Fabienne Doffey-Lazeyras,Rodolfo Lo Piccolo,Yves Chalandon,Christina Peters,Youssef Daali,Marc Ansari

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference49 articles.

1. Endocrinological late complications after hematopoietic SCT in children;Cohen;Bone Marrow Transplant.,2008

2. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant;Faraci;Int J Radiat Oncol Biol Phys.,2005

3. Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens;Grochow;Semin Oncol.,1993

4. Should busulfan therapeutic range be narrowed in pediatrics? Experience from a large cohort of hematopoietic stem cell transplant children;Philippe;Bone Marrow Transplant.,2016

5. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation;Bartelink;Biol Blood Marrow Transplant.,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-04

2. Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study;Blood Advances;2024-01-12

3. Clinical Relevance of Therapeutic Drug Monitoring of Busulfan-Based Regimens in Adult Hematopoietic Stem Cell Transplant Patients;Archives of Pharmacy Practice;2024

4. PEG 400 Ion Suppression in Busulfan Detection by High-Performance Liquid Chromatography—Tandem Mass Spectrometry;Therapeutic Drug Monitoring;2023-09-07

5. Busulfan Interlaboratory Proficiency Testing Program Revealed Worldwide Errors in Drug Quantitation and Dose Recommendations;Therapeutic Drug Monitoring;2023-05-12